Formosa Pharmaceuticals Announces Licensing Agreement with E

Formosa Pharmaceuticals Announces Licensing Agreement with Eyenovia, Inc., for the Commercialization of APP13007 for the Treatment of Inflammation and Pain Following Ocular Surgery

/PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TWO) announced today that the company has entered into a licensing agreement with...

Related Keywords

Taipei , T Ai Pei , Taiwan , Formosa Pharma , Nasdaq , Drug Administration , Prnewswire Formosa Pharmaceuticals , Eyenovia Inc , Formosa Pharmaceuticals Inc , Formosa Pharmaceuticals , Prescription Drug User Fee Act , About Formosa Pharmaceuticals ,